Search results
Author(s):
Michael Tittelbach
,
Tobias Diener
Added:
3 years ago
Since the introduction of drug-eluting stents (DES), physicians have tried to find a delicate balance between achieving a highly effective result without compromising the safety of the patient. Various concepts have been introduced into the marketplace in the attempt to identify the optimal combination of characteristics; however, until now very little attention has been paid to combining a…
View more
Author(s):
Adnan Kastrati
Added:
3 years ago
Compared with conventional bare-metal stents (BMS), the introduction of drug-eluting stents (DES) has resulted in a substantial reduction in the incidence of in-stent restenosis.1 DES systems eluting either sirolimus2 or paclitaxel3 from a polymer stent coating have been shown in randomised trials to effectively inhibit the process of neointimal proliferation, resulting in restenosis reduction.
…
View more
Drug-eluting Balloon Analysis
Author(s):
Alexander Ruebben
,
Juergen Boeing
,
Norbert Weiss
Added:
3 years ago
Article
Author(s):
Gunnar Tepe
,
Bruno Scheller
,
Ulrich Speck
Added:
3 years ago
Percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA) are established, proven methods for re-opening stenotic or occluded arteries in a minimally invasive way. The balloon is placed in the stenotic segment of the artery and then expanded until the lumen reaches its original diameter. To this end, very high pressure (up to 15 bar) is applied, which…
View more
Advances in New Stent Designs without a Permanent Polymer May Solve Polymer-related Complications
Author(s):
Chourmouzios A Arampatzi
,
Raul Moreno
,
Giuseppe Sangiorgi
Added:
3 years ago
Article
The Endovascular Approach to Treatment of Critical Limb Ischaemia Patients with Below-knee Pathology
Author(s):
Marc Bosiers
,
Alessandra Puggioni
,
Koen Deloose
,
et al
Added:
3 years ago
Article
Author(s):
Christoph Hehrlein
Added:
3 years ago
Percutaneous coronary interventions (PCI) for the treatment of coronary artery obstructions are associated with a high rate of restenosis (20–57%) in the first six months after the procedure.1,2 Metallic stenting has significantly improved short-term procedural outcomes and reduced restenosis rates in patients undergoing PCI.3,4 The surgical stent deployment procedure initially involves the…
View more
Author(s):
Bruno Scheller
,
Bodo Cremers
,
Stephanie Schmitmeier
,
et al
Added:
3 years ago
One of the most innovative fields of modern medical research is the percutaneous transluminal treatment of vascular disease. Coronary angioplasty was clinically introduced by Andreas Grüntzig in 1977.1 In the coronary field the most important improvement in angioplasty has been achieved with the introduction of stents. A significant proportion of complex modern coronary interventional techniques…
View more
Author(s):
Anouar Belkacemi
,
Pierfrancesco Agostoni
,
Michiel Voskuil
,
et al
Added:
3 years ago
In the past few decades, major progress has been made in the percutaneous treatment of coronary artery disease. Initially, the emergence of balloon angioplasty offered an alternative option for coronary revascularisation. However, abrupt closure and restenosis caused by elastic recoil, neointimal hyperplasia and late remodelling were major drawbacks of balloon angioplasty.1 The use of drug…
View more
Author(s):
Robert A Byrne
,
Eric Eeckhout
,
Gennaro Sardella
,
et al
Added:
3 years ago
Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are established strategies for revascularisation in patients with coronary artery disease. While CABG was the standard of care for patients with multivessel disease, the introduction of baremetal stents (BMSs) and, later, drug-eluting stents (DESs) has led to an increased use of PCI in these more challenging cases…
View more